The Paris Technology and Life Sciences team advised Kurma Partners, Bpifrance Investissement, BNP Paribas Développement and Majycc e-Santé Invest in the €4,3 million Series Seed financing round of NaoX Technologies, a start-up developing new generation electroencephalographic sensors.
The company's earphones integrated sensors passively record the electroencephalogram in real life by detecting vibrations of the brain and aggregating data on the software dashboard for the attending physician, thereby enabling patients to recover from mental illness.
With this funding, NaoX Technologies plans to launch its first clinical trial for epilepsy.
Kurma Partners is a key European venture capital group specialized in healthcare and biotechnology.
Bpifrance Investissement is an investment company of Bpifrance, the French Sovereign Fund.
BNP Paribas Developpement is the investment arm of BNP Paribas that specializes in SME development.
Majycc eSanté Invest is a venture capital investment company committed to helping the entrepreneurs who want to be the architects of tomorrow's healthcare.